Trial
NCT02205476
A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery
Intervention
PF-06473871
Why stopped
B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-28